References
Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586–92. doi:10.1056/NEJM199908193410807.
ten Cate JW, Timmers H, Becker AE. Coagulopathy in ruptured or dissecting aortic aneurysms. Am J Med. 1975;59:171–6. doi:10.1016/0002-9343(75)90351-4.
Micallef-Erynaud PD, Ludlam CA. Aortic aneurysms and consumptive coagulopathy. Blood Coagul Fibrinolysis. 1991;2:477–81. doi:10.1097/00001721-199106000-00012.
Fernandez-Bustamante A, Jimeno A. Disseminated intravascular coagulopathy in aortic aneurysms. Eur J Intern Med. 2005;16:551–60. doi:10.1016/j.ejim.2005.06.015.
Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, et al. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Blood Coagul Fibrinolysis. 1994;5:829–32. doi:10.1097/00001721-199410000-00022.
Kario K, Matsuo T, Kodama K, Matsuo M, Yamamoto K, Kobayashi H. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio. Haemostasis. 1992;22:179–86.
Mannucci PM. Hemostatic drugs. N Engl J Med. 1998;23:245–53. doi:10.1056/NEJM199807233390407.
Okajima K, Kohno I, Soe G, Okabe H, Takatsuki K, Binder BR. Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency. Am J Hematol. 1994;45:16–24. doi:10.1002/ajh.2830450104.
Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol). 1980;14:41–7.
Brandrook ID, Magnani HN, Moelker HC, Morrison PJ, Robinson J, Rogers HJ, et al. ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man. Br J Clin Pharmacol. 1987;23:667–75.
Ontachi Y, Asakura H, Arahata M, Kadohira Y, Maekawa M, Hayashi T, et al. Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. Circ J. 2005;69:1150–3. doi:10.1253/circj.69.1150.
Ontachi Y, Asakura H, Omote M, Yoshida T, Matsui O, Nakao S. Kasabach–Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. Haematologica. 2005;90(Suppl):ECR29.
Grand’Maison A, Charest AF, Geerts WH. Anticoagulant use in patients with chronic renal impairment. Am J Cardiovasc Drugs. 2005;5:291–305. doi:10.2165/00129784-200505050-00002.
Avvisati G, ten Cate JW, Buller HR, Mandelli F. Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. Lancet. 1989;2:122–4. doi:10.1016/S0140-6736(89)90181-5.
Rodeghiero F, Avvisati G, Castaman G, Barbui T, Mandelli F. Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood. 1990;75:2112–7.
Sanz MA, Martin G, Gonzalez M, Leon A, Rayon C, Rivas C, et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monotherapy: a multicenter study by the PATHEMA group. Blood. 2004;103:1237–43. doi:10.1182/blood-2003-07-2462.
Hashimoto S, Koike T, Tatewaki W, Seki Y, Sato N, Azegami T, et al. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia. 1994;8:1113–5.
Koseki M, Asada N, Uryu H, Takeuchi M, Asakura H, Matsue K. Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. Int J Hematol. 2007;86:403–6. doi:10.1007/BF02983996.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kimura, Si., Odawara, J., Aoki, T. et al. Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure. Int J Hematol 89, 549–552 (2009). https://doi.org/10.1007/s12185-009-0309-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-009-0309-2